Global Myasthenia Gravis Drugs Market 2017-2021

Wednesday, March 8, 2017 Drug News
Email Print This Page Comment bookmark
Font : A-A+

LONDON, March 7, 2017 /PRNewswire/ -- Myasthenia Gravis Drugs Currently, the myasthenia gravis drugs market stands at a small

size due to limited availability of approved therapies for the complete remission of the disease. However, the anticipated approval of novel drugs such as monoclonal antibodies should help market witness strong growth during the forecast period. For
instance, Alexion Pharmaceuticals is currently developing a monoclonal antibody, Soliris, for the treatment of myasthenia gravis. Once launched around end 2017 or beginning of 2018, this drug is expected to be the blockbuster drug for the market. Technavio's analysts forecast the global myasthenia gravis drugs market to grow at a CAGR of 13.16% during the period 2017-2021. Covered in this report The report covers the present scenario and the growth prospects of the global myasthenia gravis drugs market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of myasthenia gravis drugs. The market is divided into the following segments based on geography: - Americas - APAC - EMEA Technavio's report, Global Myasthenia Gravis Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Key vendors - Flamel Technologies - F. Hoffmann-La Roche - Grifols - Pfizer - Shire - Valeant Pharmaceuticals Other prominent vendors - Alexion Pharmaceuticals - Catalyst Pharmaceuticals - CSL - Curavac - Cytokinetics - Galencia - GlaxoSmithKline - Lupin Pharmaceuticals - Mitsubishi Tanabe Pharma - Novartis Market driver - Approval of novel monoclonal antibodies - For a full, detailed list, view our report Market challenge - Limited availability of approved drugs - For a full, detailed list, view our report Market trend - Emergence of new entrants - For a full, detailed list, view our report Key questions answered in this report - What will the market size be in 2021 and what will the growth rate be? - What are the key market trends? - What is driving this market? - What are the challenges to market growth? - Who are the key vendors in this market space? - What are the market opportunities and threats faced by the key vendors? - What are the strengths and weaknesses of the key vendors? You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report. Download the full report: https://www.reportbuyer.com/product/4647373/MethodologyResearch methodology is based on extensive primary and secondary research. Primary research includes in-depth interviews with industry experts, vendors, resellers and customers. Secondary research includes Technavio Platform, industry publications, company reports, news articles, analyst reports, trade associations and the data published by Government agencies.Download the full report: https://www.reportbuyer.com/product/4647373/About ReportbuyerReportbuyer is a leading industry intelligence solution that provides all market research reports from top publishershttp://www.reportbuyer.comFor more information: Sarah Smith Research Advisor at Reportbuyer.com Email: [email protected] Tel: +44 208 816 85 48 Website: www.reportbuyer.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-myasthenia-gravis-drugs-market-2017-2021-300419920.html

SOURCE ReportBuyer



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store